Tuesday, February 7, 2012

Vulcan Capital Backs Personalized Medicine Firm

Seattle-based Vulcan Capital is one of the investors in a developer of personalized medicine products. According to Applied Proteomics, which is based in San Diego, California, Vulcan joined Domain Associates and un-named angels in investing $22.5M in a Series B funding for the company. More information »